Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-04 @ 11:27 PM
Study NCT ID:
NCT01982292
Status:
COMPLETED
Last Update Posted:
2016-11-09
First Post:
2013-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-06
First Submit QC Date:
None
Study First Post Date:
2013-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-21
Results First Submit QC Date:
None
Results First Post Date:
2016-11-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-21
Last Update Post Date:
2016-11-09
Last Update Post Date Type:
ESTIMATED